Mitsui Chemicals Develops Diffrar™ Optical Polymer Wafers for AR Glasses
Werte in diesem Artikel
Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) has developed the Diffrar™ array of polymer wafers for waveguides used in augmented reality (AR) glasses, with a view to expand into the augmented and virtual reality markets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231217502683/en/

Diffrar™; 3-inch, 6-inch, 8-inch (Photo: Business Wire)
Equipped with outstanding optical properties, including a high refractive index of 1.67 or higher and extreme flatness, Diffrar™ optical polymer wafers offer users of AR glasses a wide Field Of View (FOV). In addition, the material being polymer allows Diffrar™ to have greater impact resistance, making devices safer and lighter compared to glass.
The product lineup features wafers ranging from 3 inches to 8 inches in size, providing a variety of options for module manufacturing processes for AR and other devices. The 8-inch optical polymer wafer for AR glasses is the world’s first product of this kind (according to our investigation).
The Meaning of Diffrar™
Derived from the word "diffraction” and the abbreviation of "AR,” the name Diffrar™ has been coined to express the value provided to customers where the "D” of the logo represents an opening door that to explore new products and providing value to customers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231217502683/en/
Ausgewählte Hebelprodukte auf Mitsui Chemicals
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Mitsui Chemicals
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Mitsui Chemicals Aktie News
Mitsui Chemicals Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Mitsui Chemicals nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.